Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.23M Buy
50,500
+50,000
+10,000% +$1.26M ﹤0.01% 3390
2014
Q2
$13K Sell
500
-11,500
-96% -$269K ﹤0.01% 8599
2014
Q1
$258K Sell
12,000
-38,000
-76% -$820K ﹤0.01% 4920
2013
Q4
$1.12M Buy
50,000
+49,700
+16,567% +$1.1M ﹤0.01% 3415
2013
Q3
$6K Sell
300
-900
-75% -$19.2K ﹤0.01% 9255
2013
Q2
$23K Buy
+1,200
New +$25.1K ﹤0.01% 7718

Other funds holding HOLX

UBS's HOLX Position: Q3 2014 in Review

UBS increased its Hologic (HOLX) stake by 67% in Q3 2014, buying an estimated $1.52M and bringing the position to 149,922 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

UBS first reported a position in HOLX in Q2 2013 and has held it in 6 quarters since. 353 funds tracked by Wall St. Rank hold HOLX as of Q3 2014.

  • UBS held 149,922 shares of Hologic worth $3.65M as of Q3 2014.
  • UBS bought 60,298 Hologic shares in Q3 2014, an estimated $1.52M.
  • Hologic made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2335 holding.
  • UBS first reported a position in Hologic in Q2 2013 and has held it in 6 quarters since.
  • 353 funds tracked by Wall St. Rank held Hologic as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.